Passage Bio Inc.

NASDAQ: PASG · Real-Time Price · USD
6.89
-0.70 (-9.22%)
At close: Aug 15, 2025, 3:59 PM
7.10
2.97%
After-hours: Aug 15, 2025, 07:53 PM EDT

Passage Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.38M -15.4M -12.72M -19.34M -15.99M -16.71M -16.76M -27.11M -23.86M -34.34M -27.07M -26.7M -39.54M -42.81M -51.15M -46.91M -48.44M -38.88M
Depreciation & Amortization
169K 201K 719K -403K 797K 806K 807K 958K 978K 978K 946K 929K 921K 883K 669K 460K 203K 211K
Stock-Based Compensation
923K 858K 1.25M 1.4M 1.58M 1.59M 1.57M 2.82M 3.74M 2.78M 3.48M 2.86M 6.28M 6.34M 7.58M 6.82M 8.56M 9.74M
Other Working Capital
1.01M -2.98M 3.43M 4.49M 1.41M -4.56M -2.81M -272K 1.95M 9.27M -507K 1.7M 6.26M -10.54M 10.02M -473K 3.75M -4.08M
Other Non-Cash Items
14K 2.77M -365K 7.06M 141K -444K 3.81M -6.21M -8.37M -98K -433K 1.55M 276K 2.38M 2M 5.96M 1.81M 853K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -4.66M 11.28M 8.06M n/a n/a n/a n/a n/a n/a 889K 498K 848K
Change in Working Capital
1.95M -2.27M 2.68M 3.84M 339K -4.17M -4.29M -906K 2.3M 8.23M -940K -2.04M 5.98M -11.49M 10.13M -8.26M 13.04M -3.49M
Operating Cash Flow
-6.33M -13.85M -8.44M -7.45M -13.14M -18.93M -19.52M -19.16M -17.14M -22.45M -24.02M -23.39M -26.08M -44.71M -30.77M -41.06M -24.33M -30.72M
Capital Expenditures
n/a n/a -14K -20K n/a n/a -13K -4K -103K -26K -474K -1.74M -831K -2.23M -7.32M -11.51M -5.51M -1.3M
Cash Acquisitions
585K 585K n/a n/a n/a n/a -7.61K -22.45K -14.07K -21.24K 3M 4.51K -16.84K 1.5M 8M 5.5M 1.5M 500K
Purchase of Investments
n/a n/a -15.58M -21.77M -37.02M -13.81M -27.79M -28.11M -22.13M -51.4M -41.53M -57.43M -21.47M -37.4M -32.69M -37.71M -71.82M -60.33M
Sales Maturities Of Investments
n/a 39.05M 29.27M 36.76M 38.06M 39.06M 35.41M 50.57M 36.2M 72.64M 38.65M 54.41M 38.31M 56.94M 36.4M 37.67M 67.08M 41.23M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 7.61K 22.45K 14.07K 21.24K -3M -4.51K 16.84K -1.5M -8M -5.5M -1.5M -500K
Investing Cash Flow
585K 39.63M 13.68M 14.97M 1.05M 25.25M 7.6M 22.45M 13.97M 21.22M -3.36M -4.76M 16M 17.31M -3.6M -11.55M -10.26M -20.4M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
14K n/a 47K 50K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 8.84M n/a 35K n/a n/a n/a n/a n/a -649K -408K -406K 49K 72K 44K 18K n/a
Financial Cash Flow
14K n/a 47K n/a 85K 8.74M 46K n/a 89K n/a -588 -408 -406 49.00 455.00 44.00 523.00 165.63K
Net Cash Flow
-5.73M 25.78M 5.28M 7.52M -12M 15.06M -11.87M 3.29M -3.08M -1.23M -27.97M -28.56M -10.48M -27.35M -33.92M -52.57M -34.06M 114.52M
Free Cash Flow
-6.33M -13.85M -8.46M -7.47M -13.14M -18.93M -19.53M -19.17M -17.24M -22.47M -24.5M -25.14M -26.91M -46.94M -38.09M -52.57M -29.84M -32.02M